IDEXX LABORATORIES INC /DE (IDXX) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Idexx Laboratories Inc /De quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Idexx Laboratories Inc /De Operating Income (Loss) for the quarter ending March 31, 2024 was $299 M, a 6.62% increase year-over-year.
  • Idexx Laboratories Inc /De Operating Income (Loss) for the twelve months ending March 31, 2024 was $1.12 B, a 19.9% increase year-over-year.
  • Idexx Laboratories Inc /De annual Operating Income (Loss) for 2023 was $1.1 B, a 22.1% increase from 2022.
  • Idexx Laboratories Inc /De annual Operating Income (Loss) for 2022 was $899 M, a 3.57% decline from 2021.
  • Idexx Laboratories Inc /De annual Operating Income (Loss) for 2021 was $932 M, a 34.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.12 B $299 M +$18.6 M +6.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.1 B $245 M +$18.8 M +8.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.08 B $275 M +$30.5 M +12.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $1.05 B $296 M +$117 M +65.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $931 M $280 M +$32.1 M +12.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $899 M $227 M +$27.3 M +13.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $871 M $245 M +$18.9 M +8.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $853 M $179 M -$80.2 M -30.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $933 M $248 M +$722 K +0.29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $932 M $199 M +$14.1 M +7.62% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $918 M $226 M +$54.1 M +31.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $864 M $259 M +$66 M +34.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $798 M $248 M +$103 M +71.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $695 M $185 M +$69.5 M +60.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $625 M $172 M +$32.1 M +22.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $593 M $193 M +$29 M +17.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $564 M $144 M +$11.2 M +8.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $553 M $116 M +$284 K +0.25% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-14
Q3 2019 $553 M $140 M +$22.5 M +19.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $530 M $164 M +$18.7 M +12.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $511 M $133 M +$20.1 M +17.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $491 M $115 M +$17.5 M +17.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $474 M $117 M +$16.9 M +16.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-14
Q2 2018 $457 M $146 M +$23 M +18.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-14
Q1 2018 $434 M $113 M +$20.8 M +22.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-14
Q4 2017 $413 M $97.8 M +$14 M +16.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-15
Q3 2017 $399 M $100 M +$12 M +13.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-15
Q2 2017 $387 M $123 M +$18.4 M +17.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-15
Q1 2017 $369 M $92.2 M +$18.5 M +25% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-15
Q4 2016 $350 M $83.8 M +$16.9 M +25.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $333 M $88.5 M +$16.6 M +23% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 $317 M $104 M +$15.9 M +18% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 $301 M $73.8 M +$990 K +1.36% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 $300 M $66.9 M +$32.1 M +92.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $268 M $71.9 M -$294 K -0.41% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $268 M $88.3 M +$5.08 M +6.11% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $263 M $72.8 M +$2.76 M +3.94% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
Q4 2014 $260 M $34.8 M -$26.5 M -43.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-17
Q3 2014 $287 M $72.2 M +$6.7 M +10.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-17
Q2 2014 $280 M $83.2 M +$4.46 M +5.66% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-17
Q1 2014 $276 M $70 M +$8.86 M +14.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-17
Q4 2013 $267 M $61.3 M -$2.1 M -3.31% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-17
Q3 2013 $269 M $65.5 M +$2.57 M +4.09% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-17
Q2 2013 $266 M $78.8 M +$2.95 M +3.89% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-17
Q1 2013 $263 M $61.2 M +$781 K +1.29% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-17
Q4 2012 $263 M $63.4 M +$8.13 M +14.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-18
Q3 2012 $254 M $62.9 M +$6.82 M +12.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-18
Q2 2012 $248 M $75.8 M +$4.52 M +6.34% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-18
Q1 2012 $243 M $60.4 M +$6.88 M +12.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-18
Q4 2011 $236 M $55.3 M +$4.5 M +8.85% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-19
Q3 2011 $232 M $56.1 M +$6.28 M +12.6% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-19
Q2 2011 $225 M $71.3 M +$16.5 M +30% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-19
Q1 2011 $209 M $53.5 M +$5.1 M +10.5% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-19
Q4 2010 $204 M $50.8 M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-17
Q3 2010 $49.8 M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-17
Q2 2010 $54.8 M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-17
Q1 2010 $48.4 M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.